CoChat

Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients

Open access

Published version of a preprint

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Low doses of the alkylating agent cyclophosphamide (CTX) mediate antiangiogenic and immunostimulatory effects, leading to potent tumoricidal activity in association with various immunotherapeutic strategies. Here, we show in rodents and cancer patients that CTX markedly promotes the differentiation of CD4+ T helper 17 (Th17) cells that can be recovered in both blood and tumor beds. However, CTX does not convert regulatory T cells into Th17 cells. Because Th17 are potent inducers of tissue inflammation and autoimmunity, these results suggest impact on the clinical management of various types of malignancies treated with alkylating agents and a potential need to optimize CTX-based immunotherapy in patients. Cancer Res; 71(3); 661–5. ©2010 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-1259

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 170

Metadata

Authors
Viaud, S., Flament, C., Zoubir, M., Pautier, P., LeCesne, A., Ribrag, V., Soria, J.-C., Marty, V., Vielh, P., Robert, C., Chaput, N., & Zitvogel, L.
Affiliations
  • Université Paris-Sud (FR)
  • Authors' Affiliations: 1Faculté de Médecine de l'Université Paris-Sud XI, Le Kremlin-Bicêtre, France; 2Institut National de la Santé et de la Recherche Médicale, U1015; 3Institut de Cancérologie Gustave Roussy; 4Center of Clinical Investigations in Biotherapies of Cancer CICBT 507; 5Service Innovations Thérapeutiques Essais Précoces (SITEP), 6Department of Medicine, 7Laboratory of Translational Research, 8Department of Dermatology, and 9Cell Therapy Unit, Institut de Cancérologie Gustave Roussy, Villejuif, France
Corresponding author
  • Chaput, Nathalie
  • Zitvogel, Laurence
Venue
Cancer Research
Published
2011-02-01
Volume
71
Issue
3
Pages
661-665
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2145291973
Cited by
170
References
20
Citations by year
2026: 4 · 2025: 5 · 2024: 15 · 2023: 15 · 2022: 10 · 2021: 9 · 2020: 11 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 9 · 2015: 8 · 2014: 16 · 2013: 13 · 2012: 11
FWCI
4.67
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
University of Washington
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
cyclophosphamide, Th17 cells, CD4+ T cells, regulatory T cells, alkylating agents, immunotherapy, tumor immunology, antiangiogenic activity, tumor-infiltrating lymphocytes, autoimmunity, inflammation
MeSH terms
Imatinib Mesylate, Adult, Aged, Animals, Antineoplastic Combined Chemotherapy Protocols, Benzamides, Cell Differentiation, Cyclophosphamide, Female, Humans, Interleukin-2, Male, Melanoma, Experimental, Mice, Inbred C57BL, Middle Aged, Neoplasms, Piperazines, Pyrimidines, Lymphocyte Subsets, Antineoplastic Agents, Alkylating, T-Lymphocytes, Regulatory, Mice, Th17 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-1259
The paper
Viaud, S., Flament, C., Zoubir, M., Pautier, P., LeCesne, A., Ribrag, V., Soria, J.-C., Marty, V., Vielh, P., Robert, C., Chaput, N., & Zitvogel, L. (2011). Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-1259

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.